Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73
+1.431.47%
Volume:7K
Turnover:644.33K
Market Cap:406.77M
PE:55.06
High:98.82
Open:97.68
Low:97.68
Close:97.30
52wk High:98.82
52wk Low:67.56
Shares:4.12M
Float Shares:4.12M
Volume Ratio:0.28
T/O Rate:0.16%
Dividend:1.55
Dividend Rate:1.57%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.64
PE(LYR):5.29

Loading ...

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Reuters
·
Aug 06

Biogen Director Lloyd Minor Disposes of 1,186 Common Shares Worth $240,351.94

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 05

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

Amgen Jolts to Record-High After Hiking FY Forecasts, Q2 Results Beat

Reuters
·
Aug 05

Amgen Shares Hit Record High; Last up 6.3% at $414.61

THOMSON REUTERS
·
Aug 05

Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise

THOMSON REUTERS
·
Aug 05

Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares

Dow Jones
·
Aug 05

Royalty Pharma PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366

THOMSON REUTERS
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Royalty Pharma Q2 Adj. EPS $1.32 Beats $1.28 Estimate, Sales $674.000M Miss $693.190M Estimate

Benzinga Earnings
·
Aug 05

Royalty Pharma Q2 Net Income Falls, Revenue Rises

MT Newswires Live
·
Aug 05

Royalty Pharma Q2 GAAP Net Income Attributable to Company Falls 44% to $18 Million; Non-GAAP Adjusted Ebitda Rises 16% to $736 Million

Reuters
·
Aug 05

Royalty Pharma Q2 Adjusted Ebitda Beats Estimates

Reuters
·
Aug 05

Royalty Pharma Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 05

Royalty Pharma: Outlook 2026 Portfolio Receipts $3,400 Mln to $3,500 Mln, Interest Paid $350 Mln to $360 Mln

THOMSON REUTERS
·
Aug 05

Amgen Inc : Scotiabank Raises Target Price to $450 from $385

THOMSON REUTERS
·
Aug 05